DexCom: 13% Revenue Growth in Q2 and the Effects of the CONNECT Study Data

DexCom focuses on continuous glucose monitoring systems and secures stable customer loyalty through the sale of single-use sensors and a growing digital ecosystem. In Q2, revenue increased by 13%, and the annual forecast was raised. With clinical evidence and the new over-the-counter platform "Stelo," DexCom is tapping into new markets beyond intensive care, particularly among type 2 diabetics and in general metabolic management. Strategic Orientation DexCom (DXCM) operates as a specialized medical technology company, whose core business...